SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as its CEO's recent "curative" claims for the GPS cancer therapy spark fervent debate and massive bullish sentiment among investors. The community is focused on the impending Phase 3 trial readout and a potential short squeeze, while also heavily contesting bearish arguments fueled by high short interest and questions of valuation.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as it secures a spot in the White House-backed eIPP for early U.S. air taxi operations and launches Uber Air services in Dubai, intensifying community discussion around its accelerating path to commercialization and FAA certification amidst strong partnerships and recent revenue beats.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp is trending amidst intense volatility driven by escalating geopolitical tensions in the Middle East, with ongoing conflict impacting oil supply routes and leading to wildly fluctuating crude prices. The community is sharply divided between those anticipating a significant short squeeze in oil-related stocks and others warning of a rapid correction, especially following a recent stock offering.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXY is actively trending amid escalating geopolitical tensions involving Iran, with many speculating on significant market volatility and a potential surge for the ETF. Conversely, a strong contingent views UVXY as a 'widowmaker' ETF, advocating for shorting its spikes due to its inherent decay and structure.

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

AN2 Therapeutics Inc

AN2 Therapeutics is surging with exceptionally high trading volume following a recent $40 million private placement financing at $2.85 per share. The community is actively debating whether its low float and current momentum will drive further gains or if the price will correct closer to the offering amount.

Vail Resorts, Inc. is a holding company, which engages in the operation of mountain resorts. It operates through the following segments: Mountain, Lodging, and Real Estate. The Mountain segment covers the operation of mountain resorts or ski areas, and related activities. The Lodging segment includes ownership of hotels, RockResorts, NPS concessionaire properties, condominium management, Colorado resort ground transportation operations, and mountain resort golf operations. The Real Estate segment owns, develops, and sells real estate in and around its resort communities. The company was founded by Pete Seibert and Earl Eaton in March 1957 and is headquartered in Broomfield, CO.

Vail Resorts Inc.

Vail Resorts is trending after reporting Q2 earnings and cutting fiscal 2026 guidance, primarily due to historically low snowfall in the Rockies. The community is actively debating management's strategy and the long-term viability of its Epic Pass model, with many questioning the stock's valuation and calling for a dividend cut.

Kohl's Corp. engages in the operation of family-oriented department stores. Its business line includes apparel, footwear, and accessories for women, men, and children, home products, beauty products, and accessories. The stores generally carry a consistent merchandise assortment with some differences attributable to regional preferences. The company was founded in 1962 and is headquartered in Menomonee Falls, WI.

Kohl`s Corp.

Kohl's Corp

Kohl's is a hot topic ahead of its impending earnings report, with community sentiment sharply divided between strong conviction in a potential short squeeze fueled by high short interest and arguments for its undervalued real estate, versus concerns over persistent retail headwinds and cautious analyst ratings.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending as investors anticipate details on its midsize vehicle and a path to profitability at an upcoming Investor Day, while recent mixed earnings showing revenue growth alongside widening losses, significant workforce layoffs, and record-low stock prices intensify community debate over its financial health and future in the luxury EV sector.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending as extreme volatility engulfs oil markets, fueled by escalating Middle East tensions, reports of tightening supply from Gulf nations, and critical uncertainty around the Strait of Hormuz. The community is sharply divided between those anticipating higher prices due to ongoing supply risks and others expecting a significant pullback as global powers discuss oil reserve releases and potential de-escalation.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending due to breakthrough ASH data for NXC-201, which showed high complete response rates in AL amyloidosis and led to an oversubscribed institutional offering. The community is buzzing about strategic hires signaling imminent BLA preparation, broader pipeline expansion into autoimmune diseases, and recent analyst coverage with significant price targets, all pointing to a potential re-rating as the company progresses through regulatory milestones.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
